Are Lotus Eye Hospit latest results good or bad?
Lotus Eye Hospital's latest results for March 2025 show a decline in sales by 5.9% to Rs 11.51 crore and a negative operating profit of Rs -0.17 crore, indicating significant challenges in profitability, despite a notable 204.17% increase in standalone net profit compared to the previous quarter. Overall, the financial performance reflects ongoing difficulties in maintaining sales and operational efficiency.
Lotus Eye Hospital & Institute has reported its financial results for the quarter ending March 2025, which indicate notable challenges in both sales and profitability. The company recorded net sales of Rs 11.51 crore, reflecting a decline of 5.9% compared to the average net sales of Rs 12.23 crore over the previous four quarters. This trend suggests difficulties in maintaining sales momentum.The operating profit (PBDIT) for the quarter was reported at Rs -0.17 crore, marking the lowest figure in the last five quarters. This decline points to a negative trend in operating profitability, with the operating profit margin at -1.48%, also the lowest in the past five quarters, indicating a decline in operational efficiency.
Additionally, the standalone net profit showed a significant change, with a reported growth of 204.17% compared to the previous quarter, although it remains important to consider the context of prior performance.
Overall, the financial results for Lotus Eye Hospital & Institute highlight significant challenges in sales and profitability as of March 2025. Furthermore, the company saw an adjustment in its evaluation, reflecting the current financial landscape.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
